🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

2,762 results for “CTI” Clear

  1. Scheduled Gradual Reduction + Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Addiction

    approved other terminated

    1 trial
  2. Secukinumab s.c. injection

    Novartis Pharmaceuticals

    Autoimmunity, Inflammation

    approved mab active

    1 trial
  3. Selective serotonin reuptake inhibitor (SSRI)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anxiety Depression

    approved small molecule active

    1 trial
  4. Sertraline Hydrochloride

    The First People's Hospital of Lianyungang

    COVID-19 Vaccine Adverse Reaction

    approved small molecule completed

    1 trial
  5. Sesame Oil

    United Therapeutics Europe Ltd

    Caloric Restriction

    approved small molecule completed

    1 trial
  6. Sham Injection

    HALOZYME THERAPEUTICS, INC.

    Type 1 Diabetes Mellitus

    approved small molecule completed

    1 trial
  7. Shenfu Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Septic Cardiomyopathy

    approved small molecule active

    1 trial
  8. Shenfu Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Myocardial Infarction

    approved small molecule completed

    1 trial
  9. Shenfu Injection

    The First People's Hospital of Lianyungang

    Septic Shock

    approved small molecule active

    2 trials
  10. Shexiang Baoxin pill(MUSKARDIA)

    Disc Medicine

    Ischemia With Non-Obstructive Coronary Artery

    approved other completed

    1 trial
  11. Shingrix powder and suspension for suspension for injection Herpes zoster vaccine (recombinant, adjuvanted), Shingrix powder and suspension for suspension for injection Herpes zoster vaccine (recombinant, adjuvanted)

    GlaxoSmithKline

    Herpes Zoster

    approved small molecule active

    1 trial
  12. Short Cycle Antiretroviral Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    approved other completed

    1 trial
  13. Sitagliptin 50mg Film-coated Tablets, Trajenta 5 mg film-coated tablets, Pioglitazone Mylan 15 mg compresse, Ozempic 0.5 mg solution for injection in pre-filled pen, Jardiance 10 mg film-coated tablets, GLUCOPHAGE 1000 mg potahované tablety, Invokana 100 mg film-coated tablets, Trulicity 1.5 mg solution for injection in pre-filled pen, Galvus 50 mg tablets, Forxiga 10 mg film-coated tablets

    The George Institute

    Type 2 Diabetes Mellitus

    approved small molecule active

    1 trial
  14. Sodium Bicarbonate Ringer's Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Septic Shock

    approved small molecule active

    1 trial
  15. Sodium Chloride 0.9%, Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    Disc Medicine

    Vulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)

    approved small molecule active

    1 trial
  16. Softacort 3,35 mg/ml colirio en solución en envases unidosis

    Laboratorios Tillomed Spain S.L.U

    Dry Eye and Meibomian Gland Dysfunction

    approved small molecule active

    1 trial
  17. Spikevax 50 micrograms dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine

    Moderna Biotech Spain

    SARS-CoV-2 infection

    approved small molecule active

    1 trial
  18. Spinraza 12 mg solution for injection

    Biogen

    Spinal Muscular Atrophy

    approved small molecule active

    1 trial
  19. Stereotactic Radiation Therapy

    GT Biopharma

    Glioblastoma

    approved other terminated

    1 trial
  20. Subcutaneous glargine insulin

    Lxo Ireland Designated Activity Company

    Diabetes Mellitus

    approved small molecule completed

    1 trial
  21. Sugammadex hameln 100 mg/ml oplossing voor injectie, Naloxon HCl Accord 0,4 mg/ml, oplossing voor injectie / infusie in een voorgevulde spuit, ANEXATE 0,5 mg/5 ml, solution injectable (I.V.), REMIMAZOLAM , Sufentanil Viatris 5 microgram/ml oplossing voor injectie, Esmeron 10 mg/ml, oplossing voor injectie

    Disc Medicine

    General anesthesia

    approved small molecule active

    1 trial
  22. Sulforaphane

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    HIV Infections

    approved small molecule active

    1 trial
  23. Surabgene Lomparvovec (ABBV-RGX-314), Lucentis 10 mg/ml solution for injection in pre-filled syringe, Surabgene Lomparvovec (ABBV-RGX-314)

    AbbVie Deutschland GmbH & Co. KG

    Neovascular age-related macular degeneration

    approved small molecule active

    1 trial
  24. Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)

    GT Biopharma

    Glioblastoma

    approved other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources